SAFE TO WORK Act

The SAFE TO WORK Act (S4317) was introduced and referred to the Committee on the Judiciary on July 27, 2020. This bill proposes to establish protections from liability for businesses, non-profit organizations, and healthcare providers related to COVID-19. The bill's current status as 'referred to committee' means it is in the initial stages of the legislative process and has not advanced to a vote or further consideration. Therefore, there is no immediate financial impact on companies or sectors. There is no direct funding or appropriation associated with this bill; its impact would be regulatory, reducing potential legal costs for businesses. Companies in sectors with high public interaction, such as retail (e.g., Walmart ($WMT), Target ($TGT)), hospitality (e.g., Marriott ($MAR), Hilton ($HLT)), and healthcare providers (e.g., HCA Healthcare ($HCA), Tenet Healthcare ($THC)), would benefit from reduced litigation risk if the bill were to pass. However, as it stands, no money trail exists. Historically, similar liability protection measures have been debated during public health crises but rarely pass quickly or without significant amendments. For example, during the 2009 H1N1 pandemic, discussions around liability protection for vaccine manufacturers occurred, but no broad, economy-wide liability shield was enacted. The market did not react specifically to these discussions. The current bill's referral to committee means it faces a long legislative path, and its eventual form or passage is uncertain. Therefore, no specific companies are gaining or losing at this stage. What happens next is that the Committee on the Judiciary will review the bill. It may hold hearings, amend the bill, or choose not to advance it. There is no set timeline for committee action. Until it moves out of committee, there is no further legislative progress.